Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 133

1.

Pancreatic fatty degeneration and fibrosis as predisposing factors for the development of pancreatic ductal adenocarcinoma.

Tomita Y, Azuma K, Nonaka Y, Kamada Y, Tomoeda M, Kishida M, Tanemura M, Miyoshi E.

Pancreas. 2014 Oct;43(7):1032-41. doi: 10.1097/MPA.0000000000000159.

PMID:
24991971
2.

Differentiation of pancreatic ductal adenocarcinoma from chronic pancreatitis by PAM4 immunohistochemistry.

Shi C, Merchant N, Newsome G, Goldenberg DM, Gold DV.

Arch Pathol Lab Med. 2014 Feb;138(2):220-8. doi: 10.5858/arpa.2013-0056-OA.

3.

The spectrum of histopathological changes encountered in pancreatectomy specimens after neoadjuvant chemoradiation, including subtle and less-well-recognised changes.

Kalimuthu SN, Serra S, Dhani N, Chetty R.

J Clin Pathol. 2016 Jun;69(6):463-71. doi: 10.1136/jclinpath-2016-203604. Epub 2016 Feb 25. Review.

PMID:
26915370
4.

Pancreatic intraepithelial neoplasia and histological changes in non-neoplastic pancreas associated with neoadjuvant therapy in patients with pancreatic ductal adenocarcinoma.

Chatterjee D, Katz MH, Rashid A, Estrella JS, Wang H, Varadhachary GR, Wolff RA, Lee JE, Pisters PW, Abbruzzese JL, Fleming JB, Wang H.

Histopathology. 2013 Dec;63(6):841-51. doi: 10.1111/his.12234. Epub 2013 Sep 20.

5.

Predictors and Diagnostic Strategies for Early-Stage Pancreatic Ductal Adenocarcinoma: A Retrospective Study.

Kimura H, Ohtsuka T, Matsunaga T, Watanabe Y, Tamura K, Ideno N, Aso T, Miyazaki T, Osoegawa T, Aishima S, Miyasaka Y, Ueda J, Ushijima Y, Igarashi H, Ito T, Takahata S, Oda Y, Mizumoto K, Tanaka M.

Pancreas. 2015 Oct;44(7):1148-54. doi: 10.1097/MPA.0000000000000393.

PMID:
26284536
6.

Ablation of sensory neurons in a genetic model of pancreatic ductal adenocarcinoma slows initiation and progression of cancer.

Saloman JL, Albers KM, Li D, Hartman DJ, Crawford HC, Muha EA, Rhim AD, Davis BM.

Proc Natl Acad Sci U S A. 2016 Mar 15;113(11):3078-83. doi: 10.1073/pnas.1512603113. Epub 2016 Feb 29.

7.

Intraoperative irrigation cytology of the remnant pancreas to detect remnant distinct pancreatic ductal adenocarcinoma in patients with intraductal papillary mucinous neoplasm undergoing partial pancreatectomy.

Mori Y, Ohtsuka T, Tamura K, Ideno N, Aso T, Kono H, Nagayoshi Y, Ueda J, Takahata S, Aishima S, Ookubo F, Oda Y, Tanaka M.

Surgery. 2014 Jan;155(1):67-73. doi: 10.1016/j.surg.2013.06.059. Epub 2013 Oct 29.

PMID:
24183345
8.

Presence of pancreatic intraepithelial neoplasia-3 in a background of chronic pancreatitis in pancreatic cancer patients.

Hwang IK, Kim H, Lee YS, Kim J, Cho JY, Yoon YS, Han HS, Hwang JH.

Cancer Sci. 2015 Oct;106(10):1408-13. doi: 10.1111/cas.12744. Epub 2015 Sep 4.

9.

The prognostic influence of intrapancreatic tumor location on survival after resection of pancreatic ductal adenocarcinoma.

Ruess DA, Makowiec F, Chikhladze S, Sick O, Riediger H, Hopt UT, Wittel UA.

BMC Surg. 2015 Nov 28;15:123. doi: 10.1186/s12893-015-0110-5.

10.

Increased CDC20 expression is associated with pancreatic ductal adenocarcinoma differentiation and progression.

Chang DZ, Ma Y, Ji B, Liu Y, Hwu P, Abbruzzese JL, Logsdon C, Wang H.

J Hematol Oncol. 2012 Apr 4;5:15. doi: 10.1186/1756-8722-5-15.

11.

The role of inflammation in pancreatic cancer.

Hausmann S, Kong B, Michalski C, Erkan M, Friess H.

Adv Exp Med Biol. 2014;816:129-51. doi: 10.1007/978-3-0348-0837-8_6. Review.

PMID:
24818722
12.

[Clinicopathologic characteristics of fibrous mass-forming chronic pancreatitis].

Chang XJ, Chen Y, Zhang J, Shi M, Wang Y, Zhu MH.

Zhonghua Bing Li Xue Za Zhi. 2013 Jun;42(6):366-71. doi: 10.3760/cma.j.issn.0529-5807.2013.06.003. Chinese.

PMID:
24060068
13.

The efficacy of adjuvant therapy for pancreatic invasive intraductal papillary mucinous neoplasm (IPMN).

McMillan MT, Lewis RS, Drebin JA, Teitelbaum UR, Lee MK, Roses RE, Fraker DL, Vollmer CM.

Cancer. 2016 Feb 15;122(4):521-33. doi: 10.1002/cncr.29803. Epub 2015 Nov 20.

14.

[Chronic pancreatitis as a risk factor for the development of pancreatic cancer--diagnostic challenges].

Pickartz T, Mayerle J, Kraft M, Evert M, Evert K, Kühn JP, Heidecke CD, Lerch MM.

Med Klin (Munich). 2010 Apr;105(4):281-5. doi: 10.1007/s00063-010-1042-6. German.

PMID:
20455050
15.

Adipose Triglyceride Lipase (ATGL) Expression Is Associated with Adiposity and Tumor Stromal Proliferation in Patients with Pancreatic Ductal Adenocarcinoma.

Grace SA, Meeks MW, Chen Y, Cornwell M, Ding X, Hou P, Rutgers JK, Crawford SE, Lai JP.

Anticancer Res. 2017 Feb;37(2):699-703.

PMID:
28179319
16.

Update on the management of pancreatic cancer: surgery is not enough.

Ansari D, Gustafsson A, Andersson R.

World J Gastroenterol. 2015 Mar 21;21(11):3157-65. doi: 10.3748/wjg.v21.i11.3157. Review.

17.

Pathology of pancreatic ductal adenocarcinoma: facts, challenges and future developments.

Esposito I, Konukiewitz B, Schlitter AM, Klöppel G.

World J Gastroenterol. 2014 Oct 14;20(38):13833-41. doi: 10.3748/wjg.v20.i38.13833. Review.

18.
20.

[Chronic pancreatitis with pseudocysts?].

Veits L, Vieth M, Agaimy A.

Pathologe. 2013 May;34(3):272-5. doi: 10.1007/s00292-012-1717-2. German.

PMID:
23380876

Supplemental Content

Support Center